✦ LIBER ✦

In vivo testing of silicone rubber joint implants for lipid absorption

✍ Scribed by Meester, Walter D. ;Swanson, Alfred B.

Publisher: John Wiley and Sons
Year: 1972
Tongue: English
Weight: 334 KB
Volume: 6
Category: Article
ISSN: 0021-9304
DOI: 10.1002/jbm.820060308

No coin nor oath required. For personal study only.

✦ Synopsis

Silicone rubber implants removed from patients undergoing revision arthroplasty were examined for breakage and cracks and analyzed for lipid content. No relationship was observed between lipids extracted from the implants and the implantation time. Neither was the absorption of lipids and the incidence of breakage of the implants found to be related. Various factors contributing to the possible failure and breakage of the joint implants are discussed. *Silastic (medical grade No. 372) manufactured by the n o w Corning Corporation, Midland, Michigan.

📜 SIMILAR VOLUMES

In vitro testing of silicone rubber hear

In vitro testing of silicone rubber heart-valve poppets for lipid absorption

✍ Carmen, Raleigh ;Kahn, Paul 📂 Article 📅 1968 🏛 John Wiley and Sons 🌐 English ⚖ 306 KB

## An in vitro procedure for measuring the affinity of silicone rubber balls for The method appears to duplicate weight and volume in-Potential lipid absorption is shown to in-lipid is described. creases occasionally noted in vivo. crease with degree of cure, and decrease with filler content.

In vivo tissue reactivity of radiation-c

In vivo tissue reactivity of radiation-cured silicone rubber implants

✍ Gifford, George H. ;Merrill, Edward W. ;Morgan, Michael S. 📂 Article 📅 1976 🏛 John Wiley and Sons 🌐 English ⚖ 431 KB

## Abstract Silicone rubber implants are clinically used in large numbers and elicit a mild tissue reaction. An occasional patient develops an accentuated reaction, an observation which has stimulated clinicians to try to understand this process more fully. The chemistry of medical silicone implant

Lipid formulation strategies for enhanci

Lipid formulation strategies for enhancing intestinal transport and absorption of P-glycoprotein (P-gp) substrate drugs: In vitro/In vivo case studies

✍ Panayiotis P. Constantinides; Kishor M. Wasan 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 277 KB 👁 1 views

The intestinal efflux pump, P-glycoprotein (P-gp), located in the apical membranes of intestinal absorptive cells, can reduce the bioavailability of a wide range of drugs which are substrates for this membrane transporter. In addition to anticancer and anti-HIV drugs, NCEs for other disease indicati